Caption Management, LLC Biocryst Pharmaceuticals Inc Transaction History

Caption Management, LLC

$5.74 Billion
Q3 2024

A detailed history of Caption Management, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Caption Management, LLC holds 20,000 shares of BCRX stock, worth $153,400. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,000

Previous 72,100 72.26%

Holding current value

$153,400

Previous $445,000 65.84%

% of portfolio

0.0%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$6.41 - $8.69 $128,200 - $173,800	20,000 New	20,000 $152,000
Q1 2024 May 15, 2024	BUY	$4.89 - $7.65 $293,400 - $459,000	60,000 New	60,000 $304,000
Q1 2023 May 15, 2023	SELL	$7.94 - $11.84 $313,630 - $467,680	-39,500 Reduced 70.79%	16,300 $135,000
Q4 2022 Feb 14, 2023	SELL	$10.5 - $14.2 $994,350 - $1.34 Million	-94,700 Reduced 62.92%	55,800 $640,000
Q3 2022 Nov 14, 2022	BUY	$10.79 - $14.81 $329,095 - $451,705	30,500 Added 25.42%	150,500 $1.9 Million
Q2 2022 Aug 15, 2022	SELL	$7.89 - $17.88 $946,800 - $2.15 Million	-120,000 Reduced 50.0%	120,000 $1.27 Million
Q1 2022 May 13, 2022	BUY	$11.56 - $19.76 $1.28 Million - $2.18 Million	110,500 Added 85.33%	240,000 $3.9 Million
Q4 2021 Feb 11, 2022	SELL	$11.18 - $15.46 $381,238 - $527,186	-34,100 Reduced 20.84%	129,500 $1.79 Million
Q3 2021 Nov 12, 2021	SELL	$14.21 - $17.65 $4.85 Million - $6.03 Million	-341,400 Reduced 67.6%	163,600 $2.35 Million
Q2 2021 Aug 16, 2021	BUY	$9.5 - $17.24 $4.8 Million - $8.71 Million	505,000 New	505,000 $7.98 Million
Q3 2019 Nov 14, 2019	SELL	$2.5 - $3.73 $11,000 - $16,412	-4,400 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$2.91 - $9.15 $59,946 - $188,490	-20,600 Reduced 82.4%	4,400 $16,000
Q1 2019 May 14, 2019	BUY	$7.38 - $9.72 $184,500 - $243,000	25,000 New	25,000 $203,000

Others Institutions Holding BCRX

# of Institutions

278

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.43B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Account

Caption Management, LLC Biocryst Pharmaceuticals Inc Transaction History